Acute Myeloid Leukemia: Ready for Prime Time? Expiration Date: 8/7/13 Androgen Deprivation Therapy: Minimizing Exposure and Mitigating Side Effects Expiration Date: 9/5/13 Use of Endobronchial Ultrasound and Endoscopic Ultrasound to Stage the
Search Results
JNCCN CE Offerings
Six (or More) Drugs in Search of a Mechanism: DNA Methyltransferase and Histone Deacetylase Inhibitors in the Treatment of Myelodysplastic Syndromes
Steven D. Gore
of gene expression by 5-Aza-2′-deoxycytidine in acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS) but not epithelial cells by DNA-methylation-dependent and -independent mechanisms . Leukemia 2005 ; 19 : 103 – 111 . 8
NCCN Task Force Report: Molecular Markers in Leukemias and Lymphomas
Jerald P. Radich, Andrew D. Zelenetz, Wing C. Chan, Carlo M. Croce, Myron S. Czuczman, Harry P. Erba, Sandra J. Horning, Jane Houldsworth, B. Douglas Smith, David S. Snyder, Hema M. Sundar, Meir Wetzler, and Jane N. Winter
; 112 : Abstract 1071 . 94 Mrozek K Marcucci G Paschka P . Clinical relevance of mutations and gene-expression changes in adult acute myeloid leukemia with normal cytogenetics: are we ready for a prognostically prioritized molecular
The Role of Flow Cytometry in Myelodysplastic Syndromes
Michael R. Loken and Denise A. Wells
S Safford M . Flow cytometric characterization of acute myeloid leukemia. Part 1: significance of light scattering properties . Leukemia 1991 ; 5 : 315 – 321 . 9. Hurwitz CA Loken MR Graham ML . Asynchronous antigen expression in B
Impact of Age and Comorbidity in Myelodysplastic Syndromes
Reinhard Stauder, Thomas Nösslinger, Michael Pfeilstöcker, Wolfgang R. Sperr, Friedrich Wimazal, Otto Krieger, and Peter Valent
and acute myeloid leukemia in Tyrol: incidence and distribution [abstract] . Onkologie 2003 ; 23 ( Suppl 5 ): S121 . Abstract P683 . 11. Germing U Strupp C Kundgen A . No increase in age-specific incidence of myelodysplastic syndromes
EPR22-104: A Comparison of the Burden of Leukemia Amongst Various Regions of the World, 1990-2019
Alaaeldin Ahmed, Chinmay Jani, Padmanabh Bhatt, Harpreet Singh, Ruchi Jani, Joseph Shalhoub, Dominic Marshall, Prudence Lam, and Justin Salciccioli
Background : Acute Myeloid Leukemia (AML) is the most common acute leukemia in adults accounting for about 80% of adult leukemia cases. In contrast, it accounts for less than 10% of children less than ten years of age. In the last two decades
CLO23-066: Risk of Secondary Malignancies After Platinum-Based Chemotherapy in Testicular Seminoma Patients: A Population-Based Study
Hiffsa Taj, Ayman Qasrawi, and Zin Myint
myeloid leukemia (SIR 11.86, CI: 5.12–23.38). Conclusions: In our study, patients with seminoma had increased risk of contralateral testis cancers. Patients with stage I who received chemotherapy did not have increased risk of other solid or hematologic
QIM23-131: A Retrospective Review of Myelodysplastic Syndrome Management (MDS) at Watson Clinic LLP: From Diagnosis to Primary Course of Treatment
Shane Burke, Galina Vugman, Noreen McGowan, and Michelle Sharrett
Comprehensive Cancer Network (NCCN) Guidelines recommend treatment patterns based on risk of progression into Acute Myeloid Leukemia (AML). Adherence to these guidelines improves survival rates in patients with MDS. An MDS work-up should include an extensive
CLO24-084: Myeloid Sarcoma in a Patient With Marfan Syndrome
Nitya Batra, Atulya Aman Khosla, Shyam Poudel, and Daniel Ezekwudo
myeloid leukemia (AML), however, it can occur solitarily or coexist with myelodisplastic syndrome (MDS) and other myeloproliferative neoplasms. Most common isolated sites are skin, bone, soft tissues and lymph nodes. We present a rare gastrointestinal
QIM23-137: Improving Hematology-Oncology Education in Internal Medicine Residency—A Single Institution Quality Improvement Project
Georgio Medawar, Jessica Khoury, Antoine Salloum, and John Miskovsky
prior and after a 5-lecture series. The topics covered were acute myeloid leukemia (AML), chronic lymphocytic leukemia (CLL), lung cancer, colon cancer, and breast cancer. The lectures were prepared based on National Comprehensive Cancer Center (NCCN
